Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australian Doctors Call For New Rules Against Drug Firm Influence

This article was originally published in PharmAsia News

Executive Summary

Australian physicians are pushing the government to adopt stronger regulations to block the close relationships between drug makers and health professionals. A review of Medicines Australia's code of conduct has attracted thousands of suggestions to tighten ethics rules, complete with fines as much as five times higher than current limits for violations. Some groups want fine limits to be increased to nearly $725,000. Others called for probes of what they call increasing sponsorship of "professional development" activities in clinics they say are disguised promotion of certain drugs. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069873

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel